Skip to content
value.today

BioLite, Inc.

Formerly BioLite LLC

Total raised
$4 M
1 round on record
Latest round
$4 M
Feb 2025
First round on record
Feb 2025
Today
Private
No later event on record

Funding rounds

1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of BioLite, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2025$4 MNo. 1$2 to $10 million

BioLite, Inc.: Raise no. 1, Feb 2025

Investors in this round

2 investors had bought by the notice of Mar 3, 2025: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $6 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, other: Convertible Promissory Note, and the Equity Securities Issuable upon conversion of such Convertible Promissory Note.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Derek Ewald · Executive Officer
  • Jonathan Cedar · Executive Officer, Director
  • Robb Dahir · Executive Officer
  • Amar Inamdar · Director
  • Katherine Hill · Director
  • Lyndsay Handler · Director
  • Matthew Christensen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jonathan Cedar, Chief Executive Officer. Newest notice filed Mar 3, 2025. Read the notice at the SEC.

debt, optionsSEC
Jun 2024$7 MIssued in a merger or acquisition$2 to $10 million

BioLite, Inc.: Private sale, Jun 2024

Investors in this round

1 investor had bought by the notice of Jul 2, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, other: Convertible Promissory Note, and the Equity Securities Issuable upon conversion of such Convertible Promissory Note.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Derek Ewald · Executive Officer
  • Jonathan Cedar · Executive Officer, Director
  • Robb Dahir · Executive Officer
  • Amar Inamdar · Director
  • Katherine Hill · Director
  • Lyndsay Handler · Director
  • Matthew Christensen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “The convertible promissory note was issued as consideration in a merger transaction.”

Signed by Jonathan Cedar, Chief Executive Officer. Newest notice filed Jul 2, 2024. Read the notice at the SEC.

debt, optionsSEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • BioLite, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2025).

    SEC Form D · Mar 2025

  • The industry group it chose in its notices: Other.

    SEC Form D · Mar 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of BioLite, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by BioLite, Inc.
NameRoleNamed in
Derek EwaldExecutive officerMar 2025
Jonathan CedarExecutive officerMar 2025
Robb DahirExecutive officerMar 2025
Amar InamdarDirectorMar 2025
Jonathan CedarDirectorMar 2025
Katherine HillDirectorMar 2025
Lyndsay HandlerDirectorMar 2025
Matthew ChristensenDirectorMar 2025